Publications en collaboration avec des chercheurs de Eli Lilly and Company (1)

2022

  1. Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations

    Diabetes Therapy, Vol. 13, Núm. 3, pp. 389-421